The aim of this study was to determine whether moderate restriction of dietary salt intake leads to an additional fall in blood pressure in treated hypertensive men who are asked to simultaneously reduce their usual alcohol intake. Sixty-three subjects entered an initial 2-week familiarization period during which they continued their usual alcohol intake and commenced a "low sodium" diet (less than 60 mmol/day) supplemented with 100 mmol sodium chloride per day as enteric-coated tablets. Subjects were then randomly assigned to either drink a low alcohol beer alone for a 4-week period (reducing their self-reported alcohol consumption from 537 to 57 ml/week) or to continue their usual alcohol intake (543 versus 557 ml/week). Within the low and normal alcohol intake groups, subjects were assigned to either a low or normal sodium intake. The low sodium groups continued the sodium-restricted diet but were switched to placebo sodium chloride tablets for the 4 weeks. This resulted in a fall in the 24-hour urinary sodium excretion from 144 to 69 mmol/day. The normal sodium groups continued the low sodium diet but kept taking 100 mmol/day of the sodium chloride tablets, and their urinary sodium excretion remained unchanged (125 versus 142 mmol/day). Regular antihypertensive therapy was continued throughout Fifty-nine subjects completed the trial. In those who reduced their alcohol intake there was a fall in both systolic blood pressure (-5.4 mm Hg supine, p<0.01) and diastolic blood pressure (-3.2 mm Hg supine, p<0.0l). There was no effect of salt restriction on blood pressure and no evidence of an additive effect of alcohol and salt restriction. The results indicate that, in a selected sample of treated hypertensive drinkers, a short-term and moderate reduction in salt intake in addition to a substantial decrease in alcohol intake does not lead to a greater fall in blood pressure than that seen with alcohol restriction alone. (Hypertension 1990; 16:398-406)
T he consistent demonstration of a reversible pressor effect of regular alcohol use 1 -5 suggests that reduction of alcohol intake should have high priority in the nonpharmacological management of the hypertensive drinker. Sodium restriction is now also widely promoted as an effective nonpharmacological approach in the management of mild hypertension as well as an important adjunct to pharmacological treatment in moderate and severe hypertension. 6 - 7 However, there is no evidence that a combined approach using several nonpharmacological modalities, such as alcohol restriction, a decrease in salt intake, weight reduction, or an increase in exercise, will lead to a greater fall in blood pressure than each modality alone. The alternative approach of prioritizing on an individual basis which nonpharmacological method is recommended to the hypertensive patient will lead to fewer constraints on a subject's lifestyle and conceivably better compliance. This has particular relevance to the hypertensive drinker, in whom adherence to advice to reduce alcohol intake often means substantial change in what has become a familiar and habitual lifestyle. In the present study, therefore, we assessed whether moderate sodium restriction leads to an additional fall in blood pressure in treated hypertensive drinkers who are asked to simultaneously reduce their alcohol intake.
Parker et al Salt, Alcohol, and Blood Pressure 399 providing demographic details, medical history (including all current medication), use of tobacco, and current alcohol consumption, which was assessed from a 7-day retrospective diary. From 133 completed questionnaires, 96 subjects met entry criteria, which included age between 20 and 70 years, regular treatment with antihypertensive drugs for at least the preceding 6 months, a minimum alcohol intake of 210 ml/wk (approximately three standard drinks per day), no history of renal or hepatic disease or diabetes mellitus, not on current treatment with nonsteroidal anti-inflammatory drugs, and no history of a myocardial infarction, stroke, or coronary artery bypass surgery within the previous 12 months. Sixteen of these subjects declined to participate further and 17 were excluded because testing revealed either underlying renal disease (abnormal urine sediment or a plasma creatinine greater than 130 /u.mol/1), a mean 24-hour urinary sodium excretion less than 80 mmol/ day (estimated from two urine collections 1 week apart), or failure to meet the blood pressure entry criteria. Entry blood pressure requirements were set at a systolic blood pressure of greater than or equal to 125 mm Hg but less than 180 mm Hg, and a diastolic blood pressure of less than 115 mm Hg, with mean levels averaged from two sets of five readings recorded at 2-minute intervals 1 week apart using an automatic oscillometric device, the Dinamap 845XT (Critikon Inc., Tampa, Fla.).
The remaining 63 subjects entered a 2-week familiarization period, during which a further two subjects withdrew because of illness, one declined to continue and another was withdrawn after frank glycosuria and poor blood pressure control developed, leaving 59 subjects who completed the study. The study protocol was approved by the Human Rights Committee of the University of Western Australia and all subjects gave informed consent for participation.
Study Design
Throughout the study antihypertensive therapy was maintained unchanged. During the 2-week familiarization period, all subjects were commenced on a "low sodium" diet (60 mmol/day) that was supplemented with 100 mmol enteric-coated sodium chloride given as five 10 mmol tablets twice daily. Subjects were asked to continue their usual drinking habits during this period. They were then stratified and matched as closely as possible for age, body mass index (BMI), blood pressure, and alcohol consumption before random assignment into one of four groups in a two-way factorial study of 4 weeks' duration. Two groups continued the low sodium diet but were switched on a double-blind basis to placebo tablets for enteric-coated sodium chloride for the 4 weeks. The other two groups also remained on a low sodium diet but kept taking the 100 mmol/day enteric-coated sodium chloride supplement. One each of the low and normal sodium intake groups continued their usual alcohol intake, and the other two groups reduced their alcohol consumption by substituting a low alcohol beer (0.9% alcohol vol/vol, Swan Special light Lager, Bond Brewing, Perth, Australia) for their normal drinks. To aid compliance, all four groups were provided with six 750 ml bottles per week of either low or normal alcohol content lager (5% alcohol vol/vol, Swan Lager, Bond Brewing).
Dietary Compliance
The low salt diet was designed to result in minimal alteration to the overall composition of each subject's nutrient intake. In particular, changes in fat, fiber, protein, total energy, and minerals other than sodium were avoided. Subjects were instructed not to change their eating patterns or the total amount of food intake, merely to substitute, where possible, the equivalent quantities of a low salt product. To aid compliance, they were provided with two loaves of low salt bread each week, a product not readily available in commercial outlets. Once a week, a 24-hour urine sample was collected using Memorette (Sumitomo Bakelite Co., Ltd., Tokyo) aliquot containers for measurement of sodium, potassium, calcium, magnesium, and creatinine excretion. Samples were assayed on a Technicon SMAC II multichannel autoanalyzer using standard reagents (Technicon Inc., Sydney, Australia). Subjects were then seen by a dietitian and informed whether their 24-hour urine sodium excretion fell within the target range. Compliance with the diet was further assessed by detailed food records taken on the day of urine collection. The urine was also analyzed for 24-hour excretion of free cortisol levels by radioimmunoassay. Compliance with sodium or placebo tablets was assessed by weekly tablet counts and compliance with antihypertensive medication by tablet counts before and at the end of the study period.
Alcohol Compliance
Each week during the study subjects completed a retrospective diary of the type and amount of alcohol consumed. As a further check, blood was sampled just before the intervention and again at the end of the trial for measurement of y-glutamyltranspeptidase (y-GT), plasma uric acid, erythrocyte mean corpuscular volume, serum triglycerides, and serum high density lipoprotein (HDL) cholesterol and its apolipoprotein constituents A-I and A-II, as potential biochemical and hematological markers of alcohol consumption. 89 Blood samples were also analyzed for atrial natriuretic peptide and plasma renin activity by radioimmunoassay.
Blood Pressure Measurement
Blood pressure was measured once a week at approximately the same time of day each visit, with subjects assessed in a non-fasting state. They were asked to abstain from cigarettes, coffee, and vigorous exercise for at least 2 hours beforehand. A sphygmomanometer cuff appropriate to arm circumference was applied to the right arm, and systolic and dia- Values are mean±SEM. BMI, body mass index; BP, blood pressure; HR, heart rate.
stolic blood pressure and heart rate were measured using the semiautomatic Dinamap oscillometric recorder to eliminate observer bias. Levels were averaged from 10 supine readings taken at 2-minute intervals for 20 minutes and five standing readings recorded at 1-minute intervals during a further 5 minutes. In the last week of the familiarization period and the final week of the intervention period, blood pressure was recorded according to this protocol on two separate days, the results averaged, and the mean difference calculated for subsequent treatment comparisons among the four groups.
Other Variables
A health and lifestyle questionnaire was completed the day before the intervention commenced and a shorter questionnaire at the end of the trial to assess possible changes in tea and coffee consumption, smoking habit, or physical activity. Height was measured at baseline by means of a stadiometer, and body weight was recorded at every visit by using a calibrated beam balance (Mercury, Adelaide, Australia), with subjects in light clothing and without shoes.
Statistical Analysis
A two-way analysis of variance model with interaction was used to compare changes in blood pressure, heart rate, and weight among the four groups. Intragroup comparisons of these changes were made using Bonferroni's method with the t statistic calculated from the mean square error term from the two-way analysis of variance. One-way analysis of variance and x 2 t e s t s were used to test for any differences in characteristics between groups at baseline. Our previous experience indicated that, on the basis of the prescribed number of blood pressure measurements and with an anticipated 15 subjects in each treatment group, the intraperson variability would be sufficiently low to allow at least 80% power at a=0.05 to detect a 5 mm Hg main effect difference in systolic blood pressure as a result of either salt restriction or reduction of alcohol intake. An a posteriori calculation indicated that the study had 95% power at a=0.05 to detect an alcohol or salt effect of this magnitude and 75% power to detect a further 5 mm Hg additive effect of sodium restriction in subjects who had simultaneously reduced their alcohol intake. Results are expressed as mean±SEM, except for plasma renin activity, which was logarithmically transformed before analysis and is therefore expressed as the geometric mean ± standard error of the log mean.
Results
Subjects had a mean age of 51.9±1.4 years, a mean systolic blood pressure of 138.3±1.7 mmHg, and a mean diastolic blood pressure of 84.6±1.1 mmHg. Their alcohol consumption averaged 481.5±27.8 ml/ wk during the initial screening period (equivalent to six to seven standard drinks per day), and mean urinary sodium excretion was 163.8±8.2 mmol/day. After random assignment, the four groups remained well-matched, with no substantial differences in alcohol consumption, age, BMI, blood pressure, heart rate, number of smokers, or urinary sodium excretion ( Table 1 ). The distribution of the number and type of antihypertensive drugs used by subjects in each group was also similar (Tables 2 and 3 ).
In the two groups that were switched to placebo tablets for enteric-coated sodium chloride for the 4 weeks, mean 24-hour urinary sodium excretion fell from 144.2±8.2 to 68.6+8.0 mmol/day (Figure 1 ). In contrast, mean urinary sodium excretion was unchanged in the other two groups (124.7±9.5 versus 141.7±7.6 mmol/day) ( Figure 1) . Similarly, in the two groups who drank a low alcohol beer alone over the 4 weeks, self-reported alcohol consumption fell from 537±46 to 57±8 ml/wk, whereas in the remaining two groups there was no significant change in usual Values represent number of subjects in each study group taking the indicated drug. ACE, angiotensin converting enzyme.
alcohol intake (543±47 versus 557±48 ml/wk) (Figure 1) .
When subjects first commenced the low sodium diet together with sodium chloride supplements, there was an increase in urinary potassium excretion (77.6±3.0 to 90.8±3.2 mmol/day, paired t test p< 0.001) and a decrease in urinary calcium excretion (5.4±0.3 to 4.8±0.3 mmol/day, paired t testp<0.05). These changes were in a similar direction in each of the four study groups. There were no further changes in urinary potassium, calcium, magnesium, or creatinine excretion during the 4-week intervention period.
In a two-way analysis of variance of the mean differences in systolic and diastolic blood pressure in each of the four treatment groups during the 4-week intervention, there was no evidence of a salt-alcohol interaction. This provides no evidence for an additive or synergistic blood pressure-lowering effect of combined alcohol and salt restriction in these treated hypertensive drinkers. A significant fall in supine and standing systolic and diastolic blood pressure was only seen in the two groups who reduced their alcohol intake, the magnitude of the fall being similar regardless of salt status (Figures 2 and 3 , Table 4 ). The main effect (relative to control) of alcohol restriction on systolic blood pressure was -5. Values represent number of subjects in each study group taking the indicated number of different antihypertensive agents. CI=-5.2, 1.0) (F lr55 =1.76, NS). The greatest fall occurred during the first week of reduced alcohol intake, with only a small additional fall over the ensuing 3 weeks (Figure 3 ). In the two groups in which alcohol intake remained unchanged, there was no significant change in blood pressure, irrespective of salt status (Figures 2 and 3, Table 4 ). There was no significant difference in the mean change in supine systolic blood pressure between the low alcohol, low salt group and the low alcohol, normal salt group (2.1 mmHg, 95% CI-0.9, 5.2) (^=0.8, NS).
There was no detectable effect of salt restriction on supine or standing systolic and diastolic blood pressure, the fall in blood pressure being, if anything, greater in the normal sodium intake group when compared with the sodium-restricted group ( Figures  2 and 4) . The main effect of salt restriction on systolic blood pressure was 1.0 mm Hg supine (95% CI=-2.8, 4.8) (F 1|55 =0.3, NS) and 2.6 mm Hg standing (95% CI=-1.9, 7.1) (F li55 =1.3, NS) and on diastolic blood pressure was 0.4 mm Hg supine (95% CI=-1.8, 2.6) (F O5 =0.3, NS) and 0.9 mm Hg standing (95% CI-2.2, 4.1) (F 1>55 =0.3, NS). There was no significant change in supine or erect heart rate with either sodium or alcohol restriction (Table 4 ).
In the 31 subjects who reduced their alcohol intake, the fall in supine diastolic blood pressure correlated significantly with self-reported change in alcohol intake (r=0.37,/>=0.043). There was a similar trend for supine systolic blood pressure (r=0.31, p=0.087). The fall in blood pressure is unlikely to have been due to changes in any other major lifestyle variable known to influence blood pressure, as an analysis of questionnaires completed before and at the end of the study showed no differences in level of physical activity, smoking habit, or tea and coffee consumption in each of the four groups. Tablet counts confirmed that compliance with antihypertensive medication and with enteric-coated sodium chloride tablets throughout the study was greater than 95% for each of the study groups. A significant fall in weight, of similar magnitude in all four groups, was seen from the screening period to the end of famil-
FIGURE 3. Line graph showing group mean (and SEM) systolic and diastolic blood pressures (B.P.) in the low and normal alcohol intake groups. O-O Low alcohol intake (n=31); •-•normal alcohol intake (n=28).
iarization (i.e., after commencement of the low sodium diet) (Figure 2 ). However, a continuing small decline in weight in all four groups during the intervention period (Table 4) was not statistically significant and was not significantly different between groups by analysis of variance. Weight change during the intervention did not correlate with changes in supine systolic or diastolic blood pressure. In subjects who switched to a low alcohol beer, there was no correlation between weight change and change in alcohol intake.
Before the intervention, there was a significant correlation between self-reports of alcohol intake and a number of biochemical markers of alcohol consumption including HDL cholesterol (r=0.32, p<0.05), r G T (r=0.30,p<0.05), apolipoprotein A-I (r=0.39, p<0.01), apolipoprotein A-II (r=0.44, p<0.001), and uric acid (r=0.33,/><0.05). Analysis of weekly diaries of alcohol intake during the 4-week intervention period revealed that 13 of the 31 subjects in the low alcohol group consumed an alcoholic beverage other than low alcohol beer on 25 separate occasions. The validity of the self-reported decrease in alcohol consumption was supported by a corresponding fall in HDL cholesterol and its apolipoproteins A-I and A-II (Table 5) , which were the three biochemical markers that also had the highest correlation with initial alcohol intake. There was no significant change in biochemical markers in the two groups that maintained their usual alcohol intake ( Table 5 ). The self-reported change in alcohol intake for all subjects during the study correlated highly with change in HDL cholesterol (r=0. Alcohol restriction did not result in significant changes in plasma renin activity, atrial natriuretic peptide, urinary free cortisol excretion, total plasma protein, plasma albumin, or hematocrit (Table 5) . Sodium restriction also failed to influence atrial natriuretic peptide levels, total plasma protein, plasma albumin, or hematocrit but was associated with an increase in plasma renin activity (1.70±0.47
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FIGURE 4. Group mean (and SEM) systolic and diastolic blood pressures (B.P.) in the low and normal salt intake groups. A-A Low salt intake (n=31); A-A normal salt intake (n=28).
to 2.24±0.57 ng angiotensin I/ml/hr, paired t test /><0.05) and a fall in urinary free cortisol excretion (91.4±6.9 to 76.4±7.2 mmol/1, paired t test/?<0.05).
Discussion
This study demonstrates that in the treated hypertensive drinker during a 4-week intervention, the combined approach of limiting both alcohol and salt intake does not lead to a greater fall in blood pressure than that seen with alcohol restriction alone.
The absence of a detectable effect of moderately severe dietary salt restriction is of interest in view of a number of reports of a blood pressure-lowering effect of similar degrees of sodium restriction in untreated hypertensive subjects.
10
- 11 The present study design was based on an approach previously taken by MacGregor et al, 10 who were able to demonstrate a mean fall in blood pressure of 7 mm Hg in untreated hypertensive subjects who reduced their urinary sodium excretion from 162 to 86 mmol/day over a 4-week period. Our subjects, who had a mean urinary sodium excretion of approximately 160 mmol/day at recruitment, reduced their salt intake by a similar degree with a fall from 144 to 69 mmol/day during the intervention. However, the average supine blood pressure of the subjects in the study of MacGregor et al 10 was substantially higher than that in our study (156/98 versus 138/85 mm Hg), and it is possible that moderate sodium restriction had little additional impact in our subjects where blood pressure had already been reduced by drugs. It is also conceivable that the type of antihypertensive drug treatment may have biased the outcome. However, a recent review of salt restriction as adjunctive treatment in hypertensive patients receiving drugs concluded that it appeared to augment the blood pressure-lowering effects of /3-adrenergic blockers, thiazide diuretics, and converting enzyme inhibitors but perhaps not of calcium channel antagonists. 7 Only four of the 31 subjects in the low salt group were taking calcium channel antagonists and, apart from converting enzyme inhibitors, there was a relatively even dis- Values are mean±SEM.
Significance of paired t test: *p<0.01; tp< 0.001.
•y-GT, y-glutamyltranspeptidase; MCV, mean corpuscular volume; HDL, high density lipoprotein; Ang I, angiotensin I; ANP, atrial natriuretic peptide.
tribution of each of the antihypertensive agents in the four study groups. Therefore, it is unlikely that prior drug treatment resulted in different salt sensitivity between subjects.
Another potential source of confounding is that subjects were selected on the basis of a minimal alcohol intake of 210 ml/week. This minimum criterion was established because of evidence from our previous cross-sectional study 12 of a clear-cut, alcohol-related increase in blood pressure at this level. Recruitment of subjects with lower levels of intake may have resulted in a different relative response to the two factors studied in the present experiment, especially if a higher alcohol intake reduces sensitivity of blood pressure to salt restriction by some unknown mechanism. However, such an approach would have defeated the stated aim of the study (i.e., to determine whether reduced salt intake in addition to alcohol restriction leads to an additive or synergistic effect in lowering blood pressure in treated hypertensive drinkers).
In the present study, a change to a low sodium diet was associated with an increase in urinary potassium excretion in all four study groups in the preintervention phase. No further change in urinary potassium was seen during the intervention, and it is therefore unlikely to have been a potential confounder of the outcome. However, it does reemphasize concerns that there are elements in a low sodium diet apart from sodium restriction alone that may have contributed to lowering of blood pressure in previous intervention studies. 13 It is possible that more severe sodium restriction may have produced a blood pressure-lowering effect.
14 However, a reduction of dietary salt intake to approximately 70 mmol/day is probably all that can be practically achieved in free-living subjects in Western society without substantial changes in other aspects of nutrient intake. The unpalatable nature of a severely sodium-restricted diet and the difficulty in effecting such a dietary change outside a hospital setting reduces its practical relevance in management of the treated hypertensive drinker. It is also possible that, in a study of longer duration, a blood pressurelowering effect of salt restriction may have been seen. Reports in the literature vary, and several studies have shown a sodium effect over a 4-week peri-0(^10,15,16 whereas Morgan et al, 11 in a study that was not placebo controlled, reported a sustained effect after a 2-year period. In contrast, other studies have failed to show any blood pressure response to moderate sodium restriction during 4-, 6-, and 8-week or 1-year dietary intervention periods. The possibility that patient expectation bias influenced the results must also be considered. Most of the subjects would at some stage have been made aware of the benefits of a low salt diet in the treatment of high blood pressure. Therefore, because all four groups thought they were on a low salt diet, one is left with the unlikely postulate that any expectation bias was selective for alcohol restriction alone. The striking similarity to our previous studies, 1 -2 in terms of both the magnitude of the fall in blood pressure and its time course of onset within the first week of alcohol restriction, also argues against expectation bias as an explanation for the results. Evidence that alcohol intake did change was provided not only by the subjects' self-reports but also by the significant changes in HDL cholesterol and its two major apolipoproteins, A-I and A-II.
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Moreover, these changes were directly proportional to the self-reported change in alcohol intake during the intervention period. Finally, the self-reported reduction in alcohol intake in the low alcohol group correlated with the changes seen in blood pressure, suggesting a dose-response relation that would be difficult to explain on the basis of expectation bias alone.
Alcohol consumption has been identified as a significant contributor to noncompliance with antihypertensive treatment leading to poor blood pressure control. 21 - 22 The prospect that the blood pressure changes with reduction in alcohol intake were due to improved compliance with antihypertensive drug therapy is discounted by the finding of an average overall compliance of greater than 95% with no differences among the four treatment groups. It is also unlikely that weight changes were a confounder of the results. A significant decrease in weight was observed in all four groups during the first 2 weeks of the low sodium diet, but little further change was seen during the 4-week intervention period. This suggests the weight loss was probably due to an initial change in diet that was common to all groups, with little additional influence of the subsequent change in alcohol or sodium consumption.
The finding of an effect of alcohol restriction but not salt restriction on blood pressure is consistent with the repeated cross-sectional observation of a stronger relation between alcohol intake and blood pressure than that seen with either dietary sodium 23 -25 or 24-hour urinary sodium excretion 26 - 27 and reflects the recent finding that an increase in alcohol intake is a stronger predictor of subsequent development of essential hypertension than heavy salt consumption. 28 It has previously been postulated that the alcoholblood pressure relation could be a sodium-related artifact resulting from increased dietary sodium intake in drinkers. 29 Two population studies have found a significant positive correlation between salt intake assessed by questionnaire and alcohol intake, 23 -30 but this has not been a consistent finding, 31 and when there has been control for either dietary sodium intake 23 -32 or 24-hour urinary sodium excretion, 26 -27 an independent alcohol-blood pressure relation has still been observed. Case-control studies of matched drinkers and nondrinkers have also failed to identify any differences in 24-hour urinary sodium excretion despite the presence of higher blood pressure in drinkers. 33 - 34 The results from the present study, where blood pressure fell with alcohol restriction irrespective of controlled low or normal sodium intake, provide further evidence that alcohol-related hypertension is unlikely to be secondary to excessive salt consumption by drinkers.
The etiology of alcohol-related hypertension remains undefined. The finding in several animal experiments that chronic ethanol administration is associated with increases in total body water, extracellular water, and plasma volume 35 - 38 suggests that retention of sodium and water under the influence of alcohol may play a role. During deliberate chronic administration of alcohol to human subjects 39 and in studies in alcoholics admitted for detoxification, 40 -43 there has been further evidence of chronic sodium and water retention with continued alcohol exposure. In the current study, however, alcohol restriction did not result in significant changes in plasma renin activity, atrial natriuretic peptide, total protein, albumin, hematocrit, or body weight. Moreover, as sodium restriction did not augment the alcoholrelated fall in blood pressure, it is unlikely that sodium and water retention were playing a significant role in these subjects. Such a mechanism at higher levels of alcohol intake remains a possibility.
In conclusion, our findings suggest that, in these treated hypertensive patients, blood pressure elevation may to a significant extent have been dependent on continuing alcohol consumption. They further indicate that better blood pressure control and a reduction in antihypertensive drug requirements will be more readily achieved by reduction of alcohol consumption than by reduction of sodium intake in such patients. There are other obvious health reasons why alcohol consumption should be reduced below the level of 75 ml/day seen in subjects in this study, including the need to avoid the increased risk of hemorrhagic stroke seen with heavier drinking patterns. 44 The results have not entirely excluded the possibility of a potential beneficial or harmful effect of moderate sodium restriction in these subjects, given the 95% confidence intervals for the mean change in blood pressure in the sodium-restricted groups. Moreover, a blood pressure-lowering effect of more severe or longer term salt restriction has not been ruled out. The role of other nonpharmacological modalities in the treatment of the hypertensive drinker, specifically increased physical activity and weight reduction, also needs further elucidation.
